General
Preferred name
CEFOXITIN
Synonyms
CEFOXITIN SODIUM()
Cenomycin()
MK-306()
Betacef()
Merxin()
Rephoxitin()
Cefoxitinum()
Cefoxitin sodium salt()
Cefoxitin (sodium)()
Cefoxitin (sodium salt)()
Mefoxin()
Mefoxitin()
Cefoxitina()
Cefoxitine()
J01DC01()
P&D ID
PD009557
CAS
66309-69-1
61622-34-2
35607-66-0
33564-30-6
Tags
available
covalent binder
drug
Approved by
FDA
First approval
1978
Drug indication
osteomyelitis
infection
Bacterial infection
Drug Status
approved
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE 29
DESCRIPTION Cefoxitin sodium (MK-306) is a cephalosporin-class antibiotic. Cefoxitin sodium is highly stable against ¦Â-Lactamase (HY-P2998). Cefoxitin sodium has a broad spectrum of antibacterial activity, including Gram-negative and Gram-positive bacteria[1][2][3].
DESCRIPTION Cefoxitin is a parenteral, second-generation cephamycin, β-lactam antibacterial. The 7-alpha-methoxy functional group within the structure makes cefoxitin highly resistant to hydrolysis by some β-lactamases. Methicillin-resistantStaphylococcus aureus has acquired resistance to cefoxitin,via expression of the gene for penicillin binding protein 2a (PBP2a). Cefoxitin is active against a broad range of Gram-negative and Gram-positive bacteria, including anaerobes. It is inactive against most strains ofPseudomonas aeruginosa and many strains of Enterobacter cloacae. (GtoPdb)
PRICE 29
DESCRIPTION Cefoxitin is a cephalosporin-class antibiotic. Cefoxitin is highly stable against ¦Â-Lactamase (HY-P2998). Cefoxitin has a broad spectrum of antibacterial activity, including Gram-negative and Gram-positive bacteria[1][2][3].
DESCRIPTION Cefoxitin sodium (Betacef) is a semisynthetic cephamycin antibiotic resistant to beta-lactamase. (TargetMol Bioactive Compound Library)
DESCRIPTION Cefoxitin (Rephoxitin) is a broad-spectrum, orally available second-generation cephalosporins antibiotic. Cefoxitin interferes with the synthesis of bacterial cell walls. Its activity profile includes Gram-negative and Gram-positive bacteria, and is commonly used in abdominal cavity infections, pelvic infections, and certain types of gynecological infections, and is highly effective against anaerobic bacteria. (TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
27
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
CovBinderInPDB
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
NPC Screening Collection
Other bioactive compounds
Pandemic Response Box
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
The Spectrum Collection
ZINC Tool Compounds
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
73
Molecular Weight
427.05
Hydrogen Bond Acceptors
8
Hydrogen Bond Donors
3
Rotatable Bonds
7
Ring Count
3
Aromatic Ring Count
1
cLogP
0.1
TPSA
148.26
Fraction CSP3
0.38
Chiral centers
2.0
Largest ring
6.0
QED
0.41
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
antibiotic Bacterial Cell wall Beta-lactamase Antibiotics,Bacterial
MOA
Antibiotic bacterial cell wall synthesis inhibitor
Indication
respiratory tract infections, urinary tract infections, intra-abdominal infections, gynecologic infections, bacterial septicemia, bone and joint infections, skin infections
Pathway
Microbiology/virology Immunology/Inflammation Anti-infection
Therapeutic Class
Antibiotics
Source data
